GVIA M 50MG 1000MG TABLET 28S

GVIA M 50mg/1000mg Tablets 28s:

GVIA M 50mg/1000mg Tablets 28s – Dual Action Diabetes Management

GVIA M 50mg/1000mg Tablets combine Vildagliptin 50mg and Metformin 1000mg, offering a powerful dual therapy for patients with Type 2 Diabetes Mellitus. This combination works synergistically to improve blood glucose control by enhancing insulin secretion and improving insulin sensitivity.

Key Features:

• Combination of Vildagliptin (DPP-4 inhibitor) and Metformin (Biguanide)

• Controls fasting and postprandial blood glucose levels

• Helps reduce HbA1c levels effectively

• Low risk of hypoglycemia and weight neutral

• Convenient once or twice daily dosing

• Pack Size: 28 film-coated tablets

Indications:

• Type 2 Diabetes Mellitus (T2DM) in adults

• For patients uncontrolled on metformin monotherapy

• Can be used as part of combination therapy with other antidiabetic agents

How It Works:

• Vildagliptin inhibits DPP-4 enzyme, increasing levels of incretin hormones (GLP-1 & GIP), which enhance insulin secretion and suppress glucagon release.

• Metformin lowers glucose production in the liver and improves insulin sensitivity in peripheral tissues.

Benefits:

• Targets multiple mechanisms of hyperglycemia

• Improves both beta-cell function and insulin action

• Helps maintain stable blood sugar without causing weight gain

• May reduce long-term risk of diabetes-related complications

Dosage & Administration:

• Usually taken once or twice daily with meals to minimize gastrointestinal side effects

• Dosage should be individualized based on patient needs and medical advice

Precautions:

• Not recommended in Type 1 Diabetes or diabetic ketoacidosis

• Use with caution in patients with renal or hepatic impairment

• Regular monitoring of kidney function is advised

• Common side effects may include nausea, diarrhea, or mild abdominal discomfort

Storage:

• Store below 30°C in a dry place

• Keep out of reach of children